-
June 18, 2013
FactSet is enhancing its financial and analytics database with the Fitch solution.
-
June 18, 2013
More contract wins are coming in the way of Hewlett-Packard Company.
-
June 18, 2013
As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's ...
-
June 18, 2013
On Jun 13, we retained our Neutral recommendation on Chinese energy giant PetroChina Co. Ltd.
-
June 18, 2013
AstraZeneca entered into an agreement with NGM Biopharmaceuticals, Inc. to develop candidates for type II diabetes ...
-
June 18, 2013
Incyte announced positive long-term data from two ongoing studies on Jakafi.
-
June 18, 2013
MannKind completed a phase III study on its diabetes candidate Afrezza.
-
June 18, 2013
Helix Energy Solutions Group, Inc. has closed the sale of its pipelay vessel, the Caesar, to Trevaskis Ltd.
-
June 18, 2013
Video game retail sales declined massively in May 2013
-
June 18, 2013
Perrigo has purchased Fera's eye-care portfolio.
-
June 18, 2013
Celgene presented positive results on apremilast from a phase II study.
-
June 17, 2013
According to media reports, Walmex, the Mexican subsidiary of the giant retailer, Walmart Stores, is weighing its ...
-
June 17, 2013
Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.
-
June 17, 2013
The pricing and reimbursement conditions for InterMune's Esbriet was approved in Italy.
-
June 17, 2013
XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory ...
-
June 17, 2013
Bristol-Myers and partner AbbVie presented data on elotuzumab from a phase II study.
-
June 14, 2013
UCB presented new data from the RAPID-PsA study and RAPID-axSpA study on Cimzia at the European League Against ...
-
June 14, 2013
The major issue seems to be the fact that the Xbox One requires you to log into Xbox LIVE every 24 hours in order to ...
-
June 14, 2013
Linda Pearce, chief financial officer of Nautilus recently put down her papers.
-
June 13, 2013
Actavis gained commercial rights in the US and Canada to the LNG20 intrauterine device.
